EyePoint, Inc. - Common Stock (NQ:EYPT)
5.915
+0.445
(+8.14%)
Streaming Delayed Price
Updated: 2:53 PM EDT, Aug 19, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 6,007,978 |
| Open | 6.038 |
| Bid (Size) | 5.910 (500) |
| Ask (Size) | 5.920 (400) |
| Prev. Close | 5.470 |
| Today's Range | 5.630 - 6.150 |
| 52wk Range | 3.950 - 19.11 |
| Shares Outstanding | 34,984,044 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
There are notable gap-ups and gap-downs in today's session. ↗
August 17, 2026
These stocks are moving in today's pre-market session ↗
August 17, 2026
EyePoint (EYPT) Q1 2026 Earnings Transcript ↗
May 07, 2026
EyePoint (EYPT) Q4 2025 Earnings Call Transcript ↗
March 04, 2026
The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
January 02, 2026
Frequently Asked Questions
Is EyePoint, Inc. - Common Stock publicly traded?
Yes, EyePoint, Inc. - Common Stock is publicly traded.
What exchange does EyePoint, Inc. - Common Stock trade on?
EyePoint, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for EyePoint, Inc. - Common Stock?
The ticker symbol for EyePoint, Inc. - Common Stock is EYPT on the Nasdaq Stock Market
What is the current price of EyePoint, Inc. - Common Stock?
The current price of EyePoint, Inc. - Common Stock is 5.915
When was EyePoint, Inc. - Common Stock last traded?
The last trade of EyePoint, Inc. - Common Stock was at 08/19/26 02:53 PM ET
What is the market capitalization of EyePoint, Inc. - Common Stock?
The market capitalization of EyePoint, Inc. - Common Stock is 206.93M
How many shares of EyePoint, Inc. - Common Stock are outstanding?
EyePoint, Inc. - Common Stock has 207M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.